NOBEL BIOCARE USA INC
Manufacturer adverse-event records for NOBEL BIOCARE USA INC come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2019–2024 · heavy-book · quiet Death-code · injury-heavy
Volume signature
NOBEL BIOCARE USA INC sits in the heavy MAUDE book
NOBEL BIOCARE USA INC accounts for 122,529 FDA MAUDE reports (#26 of 443, heavy-book tercile). Death-coded event_type share is 0.00% (quiet); Injury share 96.4% (injury-heavy).
What the volume reading shows for NOBEL BIOCARE USA INC
The standout signal for NOBEL BIOCARE USA INC is filing volume: 122,529 adverse-event reports in FDA MAUDE (#26 of 443, heavy-book). Death-coded event_type share sits at 0.00% (quiet).
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair NOBEL BIOCARE USA INC with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 1 device type, led in this extract by Injury at 118,111 (96.4% of event_type total). Peak single-year volume reaches 29,437 reports across 6 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (1)
| Device | Reports |
|---|---|
| Implant, Endosseous, Root-Form | 122,529 |
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.